News search

E.g., 15/02/2025
E.g., 15/02/2025
Valentín Fuster
Research
26 Aug 2022

The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

Participants who followed the TANSNIP-PESA program (orange line) showed an improvement in lifestyle measures and cardiovascular health compared with participants in the control group (who did not participate in the intervention; blue line). The Y-axis shows changes in the Fuster -BEWAT lifestyle and cardiovascular risk score with respect to the baseline value.
Research
26 Jul 2022

Adherence to a workplace cardiovascular health-promotion program improves lifestyle and risk factors in healthy individuals

Andrés Hidalgo
About the CNIC
6 Jul 2022

Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences

Juan Domingo Gisbert
About the CNIC
24 Jun 2022

Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher


Dr. Cristóbal Belda se convirtió en el nuevo Director del Instituto de Salud Carlos III.
Valentín Fuster
About the CNIC
4 Apr 2022

CNIC leader will be recognized for his exceptional achievements at the 71st annual conference


José Javier Fuster
About the CNIC
23 Feb 2022

Researchers from the CNIC and Columbia University (USA) review the role of acquired mutations and clonal hematopoiesis in cardiovascular disease

About the CNIC
27 Jan 2022

Five of the past award winners of this award subsequently received the Nobel Prize

About the CNIC
9 Jun 2021

The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide